
{
  "symbol": "GYRE",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": ["Biotechnology industry", "Small-cap company", "Phase 3 drug developments"],
    "riskScore": 7,
    "reason": "Gyre Therapeutics operates in the biotech sector, which is prone to speculation, and is a small-cap company with ongoing drug developments that attract retail interest."
  }
}
